Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“If peptides are protected from luminal proteolysis by fatty acylation, or if a nonpeptide drug, acyclovir , is esterified with valine to enhance bioavailability, the peptides nevertheless are absorbed by peptide transporters.”
Current opinion in clinical nutrition and metabolic care • 1999 | View Paper
“It has been reported that conjugating acyclovir , a potent antiviral with low oral bioavailability, to L-valine increases its urinary excretion in rats.”
“Only the mucosal-to-serosal transport of acyclovir was increased by conjugation with L-valine (approximately 7-fold), suggesting the involvement of a carrier-mediated mechanism.”
The Journal of pharmacology and experimental therapeutics • 1998 | View Paper
“If peptides are protected from luminal proteolysis by fatty acylation, or if a nonpeptide drug, acyclovir , is esterified with valine to enhance bioavailability, the peptides nevertheless are absorbed by peptide transporters.”